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AbstrACt
Objectives Chronic cough is linked to various long-
standing risk factors like asthma, chronic rhinitis and 
oesophageal reflux disease. On the contrary, acute and 
subacute cough are usually considered to be caused by 
acute respiratory infections. Little is known about the 
possible long-standing risk factors for acute and subacute 
cough. In this study, we have identified the long-standing 
risk factors for acute, subacute and chronic cough in order 
to identify the risk factors specifically associated with 
chronic cough.
Design A comprehensive 80-item questionnaire was sent 
via email to the participants.
setting A community-based study to all public service 
employees of two towns in central Finland.
Participants There were 13 980 employees, of them 
3697 responded (26.4%). Among the responders, there 
were 199 subjects with current daily acute cough (duration 
<3 weeks, prevalence 5.4%), 126 subjects with current 
daily subacute cough (duration 3–8 weeks, prevalence 
3.4%) and 267 subjects with current daily chronic cough 
(duration >8 weeks, prevalence 7.2%).
Primary outcome measures The risk factors that 
associated with each cough subtype. The subjects without 
any cough formed the reference group.
results Several risk factors were associated with both 
short and long cough subtypes namely family history of 
chronic cough, moisture damage exposure and number 
of reported somatic symptoms. Furthermore, allergy 
was associated with acute and subacute cough. Current 
asthma and chronic rhinitis were associated with subacute 
and chronic cough. Oesophageal reflux disease and 
advanced age were associated with chronic cough.
Conclusions The specific risk factors for chronic cough 
were oesophageal reflux disease and advanced age. Acute 
and subacute cough should not be regarded merely as 
symptoms of acute respiratory infections but possible 
manifestations of long-standing risk factors. A new risk 
factor for all cough types was family history of chronic 
cough.
IntrODuCtIOn 
Cough is the most common disorder for which 
people seek medical advice from a doctor.1 2 
It can be divided according to the duration: 
acute <3 weeks, subacute 3–8 weeks and 
chronic >8 weeks.3 4 Chronic cough is nowa-
days considered a manifestation of cough 
hypersensitivity syndrome, a new concept 
to describe a condition with long-standing 
hypersensitivity of vagal afferent nerves or an 
alteration of the central processing of their 
input regardless of the background disorder 
of the cough.5 6 However, effective medical 
therapy for this neuronal hypersensitivity is 
currently lacking and the management of 
chronic cough still relies on effective identi-
fication and management of the background 
disorders and other risk factors.3 4 Therefore, 
better knowledge about chronic cough risk 
factors is essential.
Acute and subacute cough have usually 
been connected to acute respiratory tract 
infections.7 8 On the contrary, chronic 
cough may be associated with long-standing 
risk factors like oesophageal reflux disease, 
asthma and rhinosinusitis.3 4 Of note, the 
information about chronic cough risk factors 
has mainly been gained from selected popu-
lations treated in specialised cough clinics. To 
our knowledge, there are just three studies in 
which the risk factors for chronic cough have 
been investigated in community samples.9–11 
strengths and limitations of this study
 ► The results are based on a large community-based 
sample of 3697 subjects.
 ► The study was from the very beginning planned to 
investigate cough risk factors and therefore includ-
ed a comprehensive list of possible risk factors and 
detailed information about current cough.
 ► The study identified subjects with acute and sub-
acute cough, in addition to chronic cough.
 ► Just 26.4% of the original population replied which 
may overestimate the cough prevalence figures.
 ► As all subjects were public service employ-
ees, low social classes and old persons are 
under-represented.
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Regurgitation, irritable bowel syndrome, smoking, 
declining social class and quality of life at baseline were 
the risk factors for chronic cough in a British study with 
4003 middle-aged subjects.9 In a Danish study with 14 669 
subjects, the three top-ranked risk factors for chronic 
cough were bronchiectasis, asthma and occupational 
exposure to dust/fumes.10 Advanced age, smoking, chest 
X-ray abnormality, asthma and diabetes were the risk 
factors for chronic cough in a Korean study with 18 071 
participants.11 Though several risk factors for chronic 
cough have been identified, the long-standing risk factors 
for acute and subacute cough are less well known. There-
fore, it is obscure whether the identified risk factors for 
chronic cough are specific for chronic cough only or, 
alternatively, might apply to all types of cough. In this 
study, we have identified the long-standing risk factors for 
acute, subacute and chronic cough in order to identify 
the risk factors specifically associated with chronic cough.
MAterIAls AnD MethODs
Population
This was a cross-sectional study among all public service 
employees of two middle-sized towns in central Finland 
(Kuopio and Jyväskylä, altogether 13 980 employees). The 
average age of this population was 46.6 years with 79.2% 
females. Invitation to the study and the questionnaire was 
sent via email to the employees’ email addresses in March 
to April 2017. Answers were collected via an electronic 
reply form. One reminding message was sent if a subject 
had not responded within 2 weeks. Permission to conduct 
the study was obtained from the town officials. The invita-
tion mail to participate the study included detailed infor-
mation about the study. The decision of the subject to 
reply was considered as an informed consent.
Questionnaire
The questions of the questionnaire have been mainly 
adopted from two previous, much used questionnaires. 
The first has been used in a Finnish annual postal survey 
entitled Health Behaviour and Health among the Finnish 
Adult Population.12 The second has been used in the 
Finnish National FINRISK Study.13 Therefore, the present 
questionnaire includes a lot of information not directly 
related to cough. The first part of the present question-
naire was filled in by all subjects. It included questions 
about the subject’s household, pets, family incomes, 
occupation, physical activity, smoking history, alcohol 
consumption, general health-related questions, current 
medications, doctor’s visits, sick leave days, recent (within 
1 month) somatic symptoms (chest pain, arthralgia, back 
pain, toothache, leg oedema, varicose disorders, eczema, 
headache, constipation, oesophageal reflux, other gastro-
intestinal symptoms, sciatica, chronic rhinosinusitis and 
wheezing) as well as all disorders diagnosed by a doctor. 
In addition, there were cough-related questions which 
were created by the authors. The second part consisted 
of 23 detailed cough-related questions to be filled by 
subjects reporting of current cough (within 2 weeks). 
Asthma-related, rhinosinusitis-related and reflux-related 
symptoms were asked by questions currently suggested for 
epidemiological studies.14–16 An electronic online supple-
mentary file includes the blank copy of the questionnaire 
(Finnish).
Definitions
Current cough was divided to subtypes. Acute cough was 
defined as current (within 2 weeks) cough that had lasted 
for less than 3 weeks, subacute cough as current cough 
that had lasted for 3–8 weeks, and chronic cough as 
current cough that had lasted for more than 8 weeks. To 
be included in the risk factor analysis, the subject’s cough 
bout frequency had to be once a day or more often. Point 
prevalence refers to the prevalence of current (within 
2 weeks) cough. The period prevalence of chronic cough 
indicated a positive answer to the question ‘Have you 
suffered from episode(s) of prolonged (over 8 weeks) 
daily or almost daily cough within the last 12 months?’
Current asthma was present if all the following condi-
tions were fulfilled: Presence of wheezing within 12 
months, dyspnoea during wheezing and wheezing also 
without respiratory tract infection. This definition was 
selected among several possible definitions14 because it 
showed the closest association with the doctor’s diagnosis 
of asthma in the present population (χ2 test, p<0.001). 
Chronic rhinosinusitis was present if there was either 
nasal blockage or nasal discharge (anterior or posterior 
nasal drip) and either facial pain/pressure or reduction/
loss of smell for more than 3 months.15 Oesophageal 
reflux disease was present if there was heartburn and/
or regurgitation on at least 1 day in a week during the 
last 3 months.16 Somatic symptom score was calculated by 
summing all reported somatic symptoms except cough, 
giving a value from 0 to 14. Allergy was defined as a self-re-
ported allergy to pollens, animals or food. Family history 
of chronic cough was defined as presence (now or in the 
past) of chronic (duration more than 8 weeks) cough in 
parents, sisters or brothers.
Patient involvement
Patients were not directly involved in the design, recruit-
ment to or conduct of this study. The results will be 
disseminated to study participants utilising Kuopio town 
and Jyväskylä town intranet portals.
statistical analysis
Descriptive data are presented as means and SDs. Bivar-
iate associations were analysed using χ2 test and Mann-
Whitney U test. The associations of the following variables 
with cough were analysed, based on plausible biological 
association with cough: age, gender, body mass index, 
years of education, family incomes, professional status, 
number of family members, pet ownership, moisture 
damage at home and at workplace, smoking history, 
alcohol consumption, level of daily physical exercise, 
family history of chronic cough, acetylsalicylic acid 
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intolerance, allergies, somatic symptom score, current 
asthma, chronic rhinosinusitis and oesophageal reflux 
disease. The variables showing at least suggestive (p<0.1) 
association with the outcome variables in the bivariate 
analyses were included in the multivariate analyses using 
binary logistic regression analysis with backward directed 
stepwise process. When analysing the risk factors for the 
cough subtypes, each subtype was compared with the 
subjects without any current cough. A p value less than 
0.05 was accepted as the level of statistical significance but 
results showing a suggestive association (p<0.1) are also 
presented. All analyses were performed using SPSS V.22 
for the personal computer (SPSS).
results
The response rate was 26.4% (3697 subjects, mean age 
47.8 (10.8) years, 82.6% females (table 1)). The propor-
tion of missing values was less than 1% in all other ques-
tions except family income (2.5%) and acetylsalicylic acid 
intolerance (1.4%). There were 23 subjects who reported 
of current cough but did not define either the cough 
frequency or duration. They were excluded from the risk 
factor analyses.
The point prevalence of acute, subacute and chronic 
cough depended on the definition of bout frequency 
(table 2). With the bout frequency of at least once a day, 
the point prevalence of acute cough was 5.4%, that of 
subacute cough 3.4% and that of chronic cough 7.2%. 
The 12-month period prevalence of daily chronic cough 
was 13.9%.
The following factors were associated with any current 
cough in the multivariate analysis: family history of 
chronic cough, moisture damage exposure, high somatic 
symptom score, allergy, current asthma, chronic rhinosi-
nusitis and advanced age (table 3). The multivariate anal-
yses about the cough subtypes are expressed in table 4. 
There were factors which showed associations with both 
short and long cough subtypes as well as factors which 
were specific for certain cough subtypes.
DIsCussIOn
In the present population consisting of working age, 
employed subjects with infrequent smoking, the risk 
factors for chronic cough were current asthma, chronic 
rhinosinusitis, oesophageal reflux disease, somatic 
symptom score, family history of chronic cough, moisture 

















Age, years 47.6 (10.8) 47.3 (10.7) 47.7 (10.3) 50.5 (10.1) 48.4 (10.9)
Female gender, % 82.2 87.9 86.5 83.1 81.0
Body mass index, kg/m2 26.4 (5.0) 27.2 (5.5) 26.6 (4.6) 27.7 (5.4) 27.0 (5.0)
Current smokers, % 6.6 8.0 7.9 8.2 7.1
Ever smokers, % 31.3 31.7 35.7 30.7 31.2
Pack-years among ever smokers 6.2 (8.8) 6.5 (9.0) 7.0 (9.9) 8.6 (10.8) 6.1 (8.6)
Family history of chronic cough, 
%
31.4 41.3 51.6 49.6 47.7
Moisture damage exposure, % 23.2 30.7 32.5 36.7 32.3
Pet ownership, % 43.7 45.2 48.8 38.0 36.4
Chronic rhinosinusitis, % 10.7 17.6 31.0 40.1 26.8
Current asthma, % 7.3 12.1 22.2 35.6 23.0
Oesophageal reflux disease, % 10.8 8.5 15.9 24.3 18.4
Somatic symptom score 2.4 (1.9) 3.0 (1.9) 3.4 (2.4) 4.0 (2.5) 3.5 (2.3)
Figures are percentages or means and SDs.
Table 2 Point prevalence of current acute, subacute, chronic and any cough with different cough bout frequency criteria
Bout frequency Acute cough (%) Subacute cough (%) Chronic cough (%) All cough (%)
Any 10.0 4.7 11.4 26.1
Once a week or more often 8.1 4.6 11.1 23.7
2–3 days a week or more often 7.3 4.3 10.0 21.6
4–6 days a week or more often 6.1 3.9 8.8 18.8
Once a day or more often 5.4 3.4 7.2 16.1
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damage exposure and advanced age. It is notable that 
several of them were also risk factors for the shorter 
cough subtypes.
The three most constantly identified risk factors for 
chronic cough, namely chronic rhinosinusitis, asthma 
and oesophageal reflux disease3 4 were associated with 
chronic cough also in the present study. Of them, oesoph-
ageal reflux disease was the only disorder specifically asso-
ciated with chronic cough whereas chronic rhinosinusitis 
and current asthma were also associated with subacute 
cough. This might be explained by the constant nature 
of oesophageal reflux. On the contrary, rhinosinusitis 
and asthma are often episodic, activated by seasonal 
allergens or upper respiratory tract infections. Advanced 
age was also specifically associated with chronic cough in 
the present study, corroborating previous reports.9–11 17 
The reason for this association is obscure. To conclude, 
oesophageal reflux disease and advanced age seem to 
be specifically connected to chronic cough. However, it 
should be highlighted that current asthma and chronic 
rhinosinusitis increased the risk of chronic cough consid-
erably more than either of them.
There are, to our knowledge, three previous communi-
ty-based studies about chronic cough risk factors. Of the 
three most constantly identified risk factors for chronic 
cough (chronic rhinosinusitis, asthma and oesophageal 
reflux), only oesophageal reflux disease was associated 
with chronic cough in the British study.9 In the Danish 
study, both chronic rhinosinusitis, asthma and oesoph-
ageal reflux disease were associated.10 In the Korean 
study, only asthma was statistically significantly associated 
with chronic cough.11 The most important difference 
between the present and the previous community-based 
studies is the use of specific, internationally recom-
mended symptom questions for all the three important 
background disorders in the present study.14–16 We did 
not want to rely on doctor’s diagnoses or registry data. 
The previous British study included only oesophageal 
reflux-related symptom questions.9 The Danish study 
included only asthma-related symptom questions.10 The 
Korean study included only chronic rhinosinusitis-re-
lated symptom questions.11 Inevitably, without adequate 
symptom questions important background disorders are 
missed. Furthermore, to strengthen the risk factor anal-
ysis in the present study, it was concentrated on daily 
cough. The Danish and the Korean studies did not report 
the cough bout frequency at all while the British study 
accepted cough with a very low bout frequency of once 
weekly.
Subacute cough shared several common risk factors 
with chronic cough in the present study, especially 
current asthma and chronic rhinosinusitis. The same 
risk factors for subacute cough were recognised also in 
two previous Korean studies.7 11 In a previous Japanese 
study, asthma was common among patients with both 
Table 3 The adjusted ORs and 95% CIs for various 
characteristics associated with any current daily cough 
(n=592), compared with subjects with no current cough 
(n=2716)
Characteristic Adjusted ORs
Family history of chronic cough 1.57 (1.30 to 1.91)***
Moisture damage exposure 1.46 (1.19 to 1.79)***
Somatic symptom score† 1.12 (1.07 to 1.18)***
Allergy 1.23 (0.97 to 1.56)
Current asthma 2.29 (1.75 to 3.00)***
Chronic rhinosinusitis 2.19 (1.71 to 2.80)***
Age‡ 1.15 (1.05 to 1.26)**
Binary logistic regression analysis with backward directed stepwise 
process. ORs are presented if p<0.10.
**P<0.01, ***P<0.001.
†OR is expressed per one somatic symptom.
‡OR is expressed per one decade.








Family history of chronic cough 1.36 (1.00 to 1.84)* 1.97 (1.36 to 2.86)*** 1.58 (1.20 to 2.09)**
Moisture damage exposure 1.35 (0.98 to 1.87) 1.50 (1.01 to 2.22)* 1.49 (1.11 to 2.00)**
Somatic symptom score† 1.13 (1.06 to 1.21)*** NS 1.11 (1.03 to 1.19)**
Allergy 1.50 (1.06 to 2.14)* 1.61 (1.06 to 2.45)* NS
Current asthma NS 2.24 (1.39 to 3.61)** 3.70 (2.63 to 5.21)***
Chronic rhinosinusitis NS 2.48 (1.62 to 3.81)*** 2.95 (2.12 to 4.10)***
Oesophageal reflux disease NS NS 1.50 (1.03 to 2.18)*
Age‡ NS NS 1.35 (1.18 to 1.54)***
Each subtype is compared with the 2716 subjects without any current cough.
ORs are presented if p<0.10. Multivariate logistic regression analysis with backward directed stepwise process.
*P<0.05, **P<0.01, ***P<0.001.
†OR is expressed per one somatic symptom.
‡OR is expressed per one decade.
NS, not significant (p>0.10).
 on 24 S
eptem









pen: first published as 10.1136/bm




5Lätti AM, et al. BMJ Open 2018;8:e022950. doi:10.1136/bmjopen-2018-022950
Open access
acute and subacute cough.8 Consistently with our study, 
oesophageal reflux disease was rare among both Korean 
and Japanese subjects with acute or subacute cough. In 
the present study, allergy was associated with acute and 
subacute cough but not with chronic cough. To conclude, 
these findings carry a clinically important message: aller-
gy-related background disorders like chronic rhinosinus-
itis and asthma are not confined to chronic cough but 
should be taken into account also in subacute cough.
To our knowledge, this is the first time when family 
history of chronic cough is recognised as a risk factor for 
cough. It was associated with all cough subtypes. Thus, it is 
not a risk factor for cough prolongation but may represent 
a heritable tendency of an individual to react with cough 
to environmental triggers. For example, a subject with 
this tendency may cough in response to respiratory viral 
infection whereas a subject without this tendency might 
predominantly react with other symptoms like rhinitis, 
fever or headache. There is a paucity of studies about 
cough inheritance. It has been shown that SLCO1B1 
genotype variants are associated with an increased risk 
of enalapril-induced cough.18 In addition, a Finnish twin 
study showed that throat clearing or coughing while 
talking may have an inherited component.19
The present study showed that an exposure to moisture 
damage is an independent risk factor for acute, subacute 
and chronic cough. This is in accordance with previous 
epidemiological studies and meta-analyses.20 This 
preventable and possibly treatable risk factor for cough 
may be under-recognised in current cough guidelines.
In the present study population, reporting of somatic 
symptoms tended to cluster in the same subjects. As a 
consequence, several odd associations were observed 
in the preliminary bivariate analysis of the present data 
(data not shown in the results section); for example, 
current cough was associated with arterial hypertension 
(p<0.001), hypercholesterolaemia (p=0.003), diabetes 
(p=0.004), toothache (p=0.019), leg oedema (p<0.001), 
headache (p<0.001) etc. In fact, almost all doctor’s diag-
nosed disorders and subject-reported symptoms showed 
bivariate associations with cough. We postulate that this 
phenomenon indicates somatisation, a condition char-
acterised by multiple somatic symptoms and associated 
with depression and anxiety. It describes the interindi-
vidual variation in how subjects recognise and report 
symptoms.21 In the present study, somatisation was taken 
into account by the somatic symptom score and only 
characteristics with plausible biological association with 
cough were included in the final analyses. We acknowl-
edge that the somatic symptom score is not a validated 
tool to investigate somatisation. However, we feel that 
somatisation is mandatory to take into account somehow 
when investigating disorders that are based on self-re-
ported symptoms. For example, when adjusting the 
analyses for the somatic symptom score, all associations 
between female gender and cough disappeared. This is 
remarkable as cough is widely considered as a disorder 
of females.22
To our knowledge, the present study for the first time 
reported both the point prevalence and period preva-
lence of chronic cough. The point prevalence of cough 
is much more seldom reported than period prevalence, 
that is, prevalence of a disorder within a wide time frame, 
usually 12 months. The point prevalence has the advan-
tage of being less subject to recall bias. Furthermore, 
considering that cough is frequently self-limiting, the 
measurement of point prevalence measure could be 
more appropriate for studying cough epidemiology.11 
There are some previous studies which present the point 
prevalence of cough but none of them reported also the 
period prevalence.9 11 17 In the present population, the 
period prevalence of chronic cough was two times higher 
than its point prevalence demonstrating the striking 
contribution of the cough prevalence definitions on the 
prevalence estimates.
The cough prevalence estimates in the present study 
may have been inflated by the relatively low response rate. 
It is possible that subjects suffering of cough may have been 
more interested to respond than those without. However, 
the responders and non-responders did not differ with 
respect to age and sex distribution. Furthermore, the 
point prevalence of chronic cough in the present study 
(11.1%) is almost same as that of the previous British 
study (12.0%) when using the same bout frequency of 
at least once a week.9 The present study showed that the 
prevalence of various forms of cough strongly depends of 
the bout frequency. To be better able to compare cough 
prevalence figures in future studies, the bout frequency 
should be reported and preferably standardised. In 
addition, point prevalence should perhaps be reported 
instead of period prevalence.
The relatively low response rate had probably less 
effect on the risk factor analyses than on the prevalence 
estimates. However, there are also other limitations in 
the present study. The generalisability of the study may 
be limited since the study subjects were public service 
employees. Low social classes and old persons are there-
fore under-represented. This may partly explain the low 
smoking rate in the present population and the fact that 
smoking was not an independent risk factor for cough. 
Women are over-represented in the present population 
but women also seek medical advice due to cough more 
often than men.22 23 All of the information used in the 
present analyses is based on self-reports in a cross-sec-
tional design with the associated problems of biased 
reporting and lack of possibility to separate associations 
from causality.
The present study is, to our knowledge, the first commu-
nity-based study about chronic cough risk factors that was 
from the very beginning planned for this purpose. There-
fore, it has some unique credits. First, it included recom-
mended symptom questions about chronic rhinosinusitis, 
current asthma and oesophageal reflux disease, together 
with a comprehensive list of other potential risk factors. 
Second, it included acute and subacute cough, besides 
chronic cough. Third, it provided detailed information 
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about current cough including the bout frequency. To 
minimise the confounding effects of acute respiratory 
infections and pollens, the questionnaires were sent 
out in March and April. Thus, the responses would be 
expected to reflect nadir of seasonal cough.
In conclusion, the present study describes the risk factors 
for acute, subacute and chronic cough. Acute and subacute 
cough should not be regarded merely as symptoms of 
acute respiratory infections but possible manifestations of 
long standing, perhaps treatable cough risk factors. Specific 
chronic cough risk factors were oesophageal reflux disease 
and advanced age. A new important risk factor for all cough 
types was family history of chronic cough.
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